Detalhe da pesquisa
1.
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study.
Leuk Lymphoma
; 60(14): 3375-3385, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31272251